Prognostic significance of EpCAM expression in human esophageal cancer

International Journal of Oncology

Volumn 30, Issue 1, 2007, Pages 171-179

  Kimura, Hitoshi ^a   Kato, Hiroyuki ^a   Faried, Ahmad ^a   Sohda, Makoto ^a   Nakajima, Masanobu ^a   Fukai, Yasuyuki ^a   Miyazaki, Tatsuya ^a   Masuda, Norihiro ^a   Fukuchi, Minoru ^a   Kuwano, Hiroyuki ^a  

^a GUNMA UNIVERSITY   (Japan)

Author keywords

ELISA; EpCAM; Esophageal cancer; Immunohistochemistry; Prognosis; Real time RT PCR

Indexed keywords

CELL ADHESION MOLECULE; PRIMER DNA; TACSTD1 PROTEIN, HUMAN; TUMOR ANTIGEN;

AGED; ARTICLE; ESOPHAGUS TUMOR; FEMALE; GENETICS; HUMAN; LYMPH NODE METASTASIS; MALE; MIDDLE AGED; MORTALITY; NUCLEOTIDE SEQUENCE; PATHOLOGY; PROGNOSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SURVIVAL; TIME;

AGED; ANTIGENS, NEOPLASM; BASE SEQUENCE; CELL ADHESION MOLECULES; DNA PRIMERS; ESOPHAGEAL NEOPLASMS; FEMALE; HUMANS; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; PROGNOSIS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SURVIVAL ANALYSIS; TIME FACTORS;

EID: 39049193839     PISSN: 10196439     EISSN: 17912423     Source Type: Journal    
DOI: 10.3892/ijo.30.1.171     Document Type: Article

References (51)

1. Gottlinger HG, Funke I, Johnson JP, Gokel JM and Riethmuller G: The epithelial cell surface antigen 17-1A, a target for antibodymediated tumor therapy: its biochemical nature, tissue distribution and recognition by different monoclonal antibodies. Int J Cancer 38: 47-53, 1986.
2. Linnenbach AJ, Wojcierowski J, Wu SA, Pyrc JJ, Ross AH, Dietzschold B, Speicher D and Koprowski H: Sequence investigation of the major gastrointestinal tumor-associated antigen gene family, GA733. Proc Natl Acad Sci USA 86: 27-31, 1989.
3. Litvinov SV, van Driel W, van Rhijn CM, Bakker HA, van Krieken H, Fleuren GJ and Warnaar SO: Expression of Ep-CAM in cervical squamous epithelia correlates with an increased proliferation and the disappearance of markers for terminal differentiation. Am J Pathol 148: 865-875, 1996.
4. Litvinov SV, Velders MP, Bakker HA, Fleuren GJ and Warnaar SO: Ep-CAM: a human epithelial antigen is a homophilic cell-cell adhesion molecule. J Cell Biol 125: 437-446, 1994.
5. Balzar M, Prins FA, Bakker HA, Fleuren GJ, Warnaar SO and Litvinov SV: The structural analysis of adhesions mediated by Ep-CAM. Exp Cell Res 246: 108-121, 1999.
6. Gumbiner BM: Cell adhesion: the molecular basis of tissue architecture and morphogenesis. Cell 84: 345-357, 1996.
7. Litvinov SV, Balzar M, Winter MJ, Bakker HA, Briaire-de Bruijn IH, Prins F, Fleuren GJ and Warnaar SO: Epithelial cell adhesion molecule (Ep-CAM) modulates cell-cell interactions mediated by classic cadherins. J Cell Biol 139: 1337-1348, 1997.
8. Balzar M, Winter MJ, De Boer CJ and Litvinov SV: The biology of the 17-1A antigen (Ep-CAM). J Mol Med 77: 699-712, 1999.
9. Basak S, Speicher D, Eck S, Wunner W, Maul G, Simmons MS and Herlyn D: Colorectal carcinoma invasion inhibition by CO17-1A/GA733 antigen and its murine homologue. J Natl Cancer Inst 90: 691-697, 1998.
10. Gires O, Kieu C, Fix P, Schmitt B, Munz M, Wollenberg B and Zeidler R: Tumor necrosis factor alpha negatively regulates the expression of the carcinoma-associated antigen epithelial cell adhesion molecule. Cancer 92: 620-628, 2001.
11. Herlyn M, Steplewski Z, Herlyn D and Koprowski H: Colorectal carcinoma-specific antigen: detection by means of monoclonal antibodies. Proc Natl Acad Sci USA 76: 1438-1442, 1979.
12. Zhang S, Zhang HS, Reuter VE, Slovin SF, Scher HI and Livingston PO: Expression of potential target antigens for immunotherapy on primary and metastatic prostate cancers. Clin Cancer Res 4: 295-302, 1998.
13. Poczatek RB, Myers RB, Manne U, Oelschlager DK, Weiss HL, Bostwick DG and Grizzle WE: Ep-Cam levels in prostatic adenocarcinoma and prostatic intraepithelial neoplasia. J Urol 162: 1462-1466, 1999.
14. de Boer CJ, van Krieken JH, Janssen-van Rhijn CM and Litvinov SV: Expression of Ep-CAM in normal, regenerating, metaplastic, and neoplastic liver. J Pathol 188: 201-206, 1999.
15. Ruck P, Wichert G, Handgretinger R and Kaiserling E: Ep-CAM in malignant liver tumours. J Pathol 191: 102-103, 2000.
16. Kumble S, Omary MB, Fajard, LF and Triadafilopoulos G: Multifocal heterogeneity in villin and Ep-CAM expression in Barrett's esophagus. Int J Cancer 66: 48-54, 1996.
17. Martin IG, Cutts SG, Birbeck K, Gray S and Quirke P: Expression of the 17-1A antigen in gastric and gastro-oesophageal junction adenocarcinomas: a potential immunotherapeutic target? J Clin Pathol 52: 701-704, 1999.
18. Kubuschok B, Passlick B, Izbicki JR, Thetter O and Pantel K: Disseminated tumor cells in lymph nodes as a determinant for survival in surgically resected non-small cell lung cancer. J Clin Oncol 17: 19-24, 1999. (Pubitemid 29022373)
19. Piyathilake CJ, Frost AR, Weiss H, Manne U, Heimburger DC and Grizzle WE: The expression of Ep-CAM (17-1A) in squamous cell cancers of the lung. Hum Pathol 31: 482-487, 2000.
20. Takes RP, Baatenburg de Jong RJ, Schuuring E, Hermans J, Vis AA, Litvinov SV and van Krieken JH: Markers for assessment of nodal metastasis in laryngeal carcinoma. Arch Otolaryngol Head Neck Surg 123: 412-419, 1997.
21. Edwards DP, Grzyb KT, Dressler LG, Mansel RE, Zava DT, Sledge GW Jr and McGuire WL: Monoclonal antibody identification and characterization of a Mr 43,000 membrane glycoprotein associated with human breast cancer. Cancer Res 46: 1306-1317, 1986.
22. Went PT, Lugli A, Meier S, Bundi M, Mirlacher M, Sauter G and Dirnhofer S: Frequent EpCam protein expression in human carcinomas. Hum Pathol 35: 122-128, 2004.
23. Gastl G, Spizzo G, Obrist P, Dunser M and Mikuz G: Ep-CAM overexpression in breast cancer as a predictor of survival. Lancet 356: 1981-1982, 2000.
24. Kim JH, Herlyn D, Wong KK, Park DC, Schorge JO, Lu KH, Skates SJ, Cramer DW, Berkowitz RS and Mok SC: Identification of epithelial cell adhesion molecule autoantibody in patients with ovarian cancer. Clin Cancer Res 9: 4782-4791, 2003.
25. Varga M, Obrist P, Schneeberger S, Muhlmann G, Felgel- Farnholz C, Fong D, Zitt M, Brunhuber T, Schafer G, Gastl G and Spizzo G: Overexpression of epithelial cell adhesion molecule antigen in gallbladder carcinoma is an independent marker for poor survival. Clin Cancer Res 10: 3131-3136, 2004.
26. Seligson DB, Pantuck AJ, Liu X, Huang Y, Horvath S, Bui MH, Han KR, Correa AJ, Eeva M, Tze S, Belldegrun AS and Figlin RA: Epithelial cell adhesion molecule (KSA) expression: pathobiology and its role as an independent predictor of survival in renal cell carcinoma. Clin Cancer Res 10: 2659-2669, 2004.
27. Songun I, Litvinov SV, van de Velde CJ, Pals ST, Hermans J and van Krieken JH: Loss of Ep-CAM (CO17-1A) expression predicts survival in patients with gastric cancer. Br J Cancer 92: 1767-1772, 2005.
28. Riethmuller G, Holz E, Schlimok G, Schmiegel W, Raab R, Hoffken K, Gruber R, Funke I, Pichlmaier H, Hirche H, Buggisch P, Witte J and Pichlmayr R: Monoclonal antibody therapy for resected Dukes' C colorectal cancer: 7-year outcome of a multicenter randomized trial. J Clin Oncol 16: 1788-1794, 1998.
29. Wimberger P, Xiang W, Mayr D, Diebold J, Dreier T, Baeuerle PA and Kimmig R: Efficient tumor cell lysis by autologous, tumor-resident T lymphocytes in primary ovarian cancer samples by an EP-CAM-/CD3-bispecific antibody. Int J Cancer 105: 241-248, 2003.
30. Maletz K, Kufer P, Mack M, Raum T, Pantel K, Riethmuller G and Gruber R: Bispecific single-chain antibodies as effective tools for eliminating epithelial cancer cells from human stem cell preparations by redirected cell cytotoxicity. Int J Cancer 93: 409-416, 2001.
31. Kufer P, Zettl F, Borschert K, Lutterbuse R, Kischel R and Riethmuller G: Minimal costimulatory requirements for T cell priming and TH1 differentiation: activation of naive human T lymphocytes by tumor cells armed with bifunctional antibody constructs. Cancer Immun 1: 10, 2001.
32. Sobin LH and Witteking CH (eds): TNM Classificaton of Malignant Tumours. 6th edition. John Wiley & Sons, Inc., New York, 2002.
33. Osta WA, Chen Y, Mikhitarian K, Mitas M, Salem M, Hannun YA, Cole DJ and Gillanders WE: EpCAM is overexpressed in breast cancer and is a potential target for breast cancer gene therapy. Cancer Res 64: 5818-5824, 2004.
34. Furuya M, Nishiyama M, Kimura S, Suyama T, Naya Y, Ito H, Nikaido T and Ishikura H: Expression of regulator of G protein signalling protein 5 (RGS5) in the tumour vasculature of human renal cell carcinoma. J Pathol 203: 551-558, 2004.
35. Kato H, Yoshikawa M, Miyazaki T, Nakajima M, Fukai Y, Masuda N, Fukuchi M, Manda R, Tsukada K and Kuwano H: Expression of vascular endothelial growth factor (VEGF) and its receptors (Flt-1 and Flk-1) in esophageal squamous cell carcinoma. Anticancer Res 22: 3977-3984, 2002.
36. Fukai Y, Masuda N, Kato H, Fukuchi M, Miyazaki T, Nakajima M, Sohda M, Kuwano H and Nakajima T: Correlation between laminin-5 gamma2 chain and epidermal growth factor receptor expression in esophageal squamous cell carcinomas. Oncology 69: 71-80, 2005.
37. Winter MJ, Nagelkerken B, Mertens AE, Rees-Bakker HA, Briaire-de Bruijn IH and Litvinov SV: Expression of Ep-CAM shifts the state of cadherin-mediated adhesions from strong to weak. Exp Cell Res 285: 50-58, 2003.
38. Mitas M, Almeida JS, Mikhitarian K, Gillanders WE, Lewin DN, Spyropoulos DD, Hoover L, Graham A, Glenn T, King P, Cole DJ, Hawes R, Reed CE and Hoffman BJ: Accurate discrimination of Barrett's esophagus and esophageal adenocarcinoma using a quantitative three-tiered algorithm and multimarker real-time reverse transcription-PCR. Clin Cancer Res 11: 2205-2214, 2005.
39. Momburg F, Moldenhauer G, Hammerling GJ and Moller P: Immunohistochemical study of the expression of a Mr 34,000 human epithelium-specific surface glycoprotein in normal and malignant tissues. Cancer Res 47: 2883-2891, 1987.
40. Harada T, Shinohara M, Nakamura S, Shimada M and Oka M: Immunohistochemical detection of desmosomes in oral squamous cell carcinomas: correlation with differentiation, mode of invasion, and metastatic potential. Int J Oral Maxillofac Surg 21: 346-349, 1992.
41. Hiraki A, Shinohara M, Ikebe T, Nakamura S, Kurahara S and Garrod DR: Immunohistochemical staining of desmosomal components in oral squamous cell carcinomas and its association with tumour behaviour. Br J Cancer 73: 1491-1497, 1996.
42. Shinohara M, Hiraki A, Ikebe T, Nakamura S, Kurahara S, Shirasuna K and Garrod DR: Immunohistochemical study of desmosomes in oral squamous cell carcinoma: correlation with cytokeratin and E-cadherin staining, and with tumour behaviour. J Pathol 184: 369-381, 1998.
43. Abe H, Kuroki M, Imakiire T, Yamauchi Y, Yamada H, Arakawa F and Kuroki M: Preparation of recombinant MK-1/ Ep-CAM and establishment of an ELISA system for determining soluble MK-1/Ep-CAM levels in sera of cancer patients. J Immunol Methods 270: 227-233, 2002.
44. Katayama M, Hirai S, Kamihagi K, Nakagawa K, Yasumoto M and Kato I: Soluble E-cadherin fragments increased in circulation of cancer patients. Br J Cancer 69: 580-585, 1994.
45. Gadducci A, Ferdeghini M, Cosio S, Annicchiarico C, Ciampi B, Bianchi R and Genazzani AR: Preoperative serum E-cadherin assay in patients with ovarian carcinoma. Anticancer Res 19: 769-772, 1999.
46. Grothey A, Heistermann P, Philippou S and Voigtmann R: Serum levels of soluble intercellular adhesion molecule-1 (ICAM-1, CD54) in patients with non-small cell lung cancer: correlation with histological expression of ICAM-1 and tumour stage. Br J Cancer 77: 801-807, 1998.
47. Trojan A, Witzens M, Schultze JL, Vonderheide RH, Harig S, Krackhardt AM, Stahel RA and Gribben JG: Generation of cytotoxic T lymphocytes against native and altered peptides of human leukocyte antigen-A*0201 restricted epitopes from the human epithelial cell adhesion molecule. Cancer Res 61: 4761-4765, 2001.
48. Jager E, Ringhoffer M, Altmannsberger M, Arand M, Karbach J, Jager D, Oesch F and Knuth A: Immunoselection in vivo: independent loss of MHC class I and melanocyte differentiation antigen expression in metastatic melanoma. Int J Cancer 71: 142-147, 1997.
49. Nagorsen D, Scheibenbogen C, Marincola FM, Letsch A and Keilholz U: Natural T cell immunity against cancer. Clin Cancer Res 9: 4296-4303, 2003.
50. Nagorsen D, Keilholz U, Rivoltini L, Schmittel A, Letsch A, Asemissen AM, Berger G, Buhr HJ, Thiel E and Scheibenbogen C: Natural T-cell response against MHC class I epitopes of epithelial cell adhesion molecule, her-2/neu, and carcinoembryonic antigen in patients with colorectal cancer. Cancer Res 60: 4850-4854, 2000.
51. Tajima K, Demachi A, Ito Y, Nishida K, Akatsuka Y, Tsujimura K, Kuwano H, Mitsudomi T, Takahashi T and Kuzushima K: Identification of an epitope from the epithelial cell adhesion molecule eliciting HLA-A*2402-restricted cytotoxic T-lymphocyte responses. Tissue Antigens 64: 650-659, 2004.